381 related articles for article (PubMed ID: 34404407)
1. Ovarian cancer: epigenetics, drug resistance, and progression.
Xie W; Sun H; Li X; Lin F; Wang Z; Wang X
Cancer Cell Int; 2021 Aug; 21(1):434. PubMed ID: 34404407
[TBL] [Abstract][Full Text] [Related]
2. Alterations of epigenetics and microRNA in hepatocellular carcinoma.
Saito Y; Hibino S; Saito H
Hepatol Res; 2014 Jan; 44(1):31-42. PubMed ID: 23617364
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.
Wang Y; Huang Z; Li B; Liu L; Huang C
Front Endocrinol (Lausanne); 2022; 13():863541. PubMed ID: 35620395
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
5. Current Concepts of Epigenetics in Testicular Cancer.
la Rosa AH; Manoharan M; Goolam AS
Indian J Surg Oncol; 2017 Jun; 8(2):169-174. PubMed ID: 28546713
[TBL] [Abstract][Full Text] [Related]
6. Molecular epigenetics in the management of ovarian cancer: are we investigating a rational clinical promise?
Nguyen HT; Tian G; Murph MM
Front Oncol; 2014; 4():71. PubMed ID: 24782983
[TBL] [Abstract][Full Text] [Related]
7. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer.
Matthews BG; Bowden NA; Wong-Brown MW
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885103
[TBL] [Abstract][Full Text] [Related]
9. The Long Non-Coding RNA
Abildgaard C; do Canto LM; Rainho CA; Marchi FA; Calanca N; Waldstrøm M; Steffensen KD; Rogatto SR
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406435
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of bone remodeling and bone metastasis.
Sharma G; Sultana A; Abdullah KM; Pothuraju R; Nasser MW; Batra SK; Siddiqui JA
Semin Cell Dev Biol; 2024 Feb; 154(Pt C):275-285. PubMed ID: 36379849
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic control of gene expression: Potential implications for cancer treatment.
Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
Li Y; Li Z; Zhu WG
Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
Fu Y; Campbell EJ; Shepherd TG; Nachtigal MW
Mol Cancer Res; 2003 Jun; 1(8):569-76. PubMed ID: 12805404
[TBL] [Abstract][Full Text] [Related]
15. The Importance of Epigenetics in Diagnostics and Treatment of Major Depressive Disorder.
Czarny P; Białek K; Ziółkowska S; Strycharz J; Barszczewska G; Sliwinski T
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33804455
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic modifications in solid tumor metastasis in people of African ancestry.
Oladipo EK; Olufemi SE; Adediran DA; Adejumo IO; Jimah EM; Oloke JK; Udekwu CC; Ogunwobi OO
Front Oncol; 2024; 14():1325614. PubMed ID: 38450190
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
18. The role of epigenetics in kidney malignancies.
la Rosa AH; Acker M; Swain S; Manoharan M
Cent European J Urol; 2015; 68(2):157-64. PubMed ID: 26251734
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA Regulation of Epigenetic Modifiers in Breast Cancer.
Humphries B; Wang Z; Yang C
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252590
[TBL] [Abstract][Full Text] [Related]
20. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
